Patents by Inventor Nikhil Khadtare

Nikhil Khadtare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS CONTAINING DOFETILIDE AND MEXILETINE AND USES THEREOF
    Publication number: 20250120930
    Abstract: Described are pharmaceutical compositions in fixed dose combinations containing: a) a dofetilide component; and b) a mexiletine component; wherein the dofetilide component and the mexiletine component are physically separated from each other, along with methods of treating or preventing atrial fibrillation or a symptom associated therewith in a subject in need thereof by administering to the subject such a pharmaceutical composition and methods of preparing such fixed dose combination products.
    Type: Application
    Filed: December 17, 2024
    Publication date: April 17, 2025
    Inventors: Nikhil Khadtare, Aruna Murty, Qun Liu
  • Compositions containing dofetilide and mexiletine and uses thereof
    Patent number: 12208070
    Abstract: Described are pharmaceutical compositions in fixed dose combinations containing: a) a dofetilide component; and b) a mexiletine component; wherein the dofetilide component and the mexiletine component are physically separated from each other, along with methods of treating or preventing atrial fibrillation or a symptom associated therewith in a subject in need thereof by administering to the subject such a pharmaceutical composition and methods of preparing such fixed dose combination products.
    Type: Grant
    Filed: May 15, 2023
    Date of Patent: January 28, 2025
    Assignee: FB-HRS, LLC
    Inventors: Nikhil Khadtare, Aruna Murty, Qun Liu
  • Compositions Containing Dofetilide and Mexiletine and Uses Thereof
    Publication number: 20230381123
    Abstract: Described are pharmaceutical compositions in fixed dose combinations containing: a) a dofetilide component; and b) a mexiletine component; wherein the dofetilide component and the mexiletine component are physically separated from each other, along with methods of treating or preventing atrial fibrillation or a symptom associated therewith in a subject in need thereof by administering to the subject such a pharmaceutical composition and methods of preparing such fixed dose combination products.
    Type: Application
    Filed: May 15, 2023
    Publication date: November 30, 2023
    Inventors: Nikhil Khadtare, Aruna Murty, Qun Liu